Variant · Snv
HABP2 NM_004132.5(HABP2):c.364C>T (p.Arg122Trp)
CI-VAR-00153210Explore in graph →p.Arg122TrpNM_004132.5:c.364C>TClinVar 877809 rs78201625
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 877809 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Factor VII-activating protease marburg I; Thrombophilia due to thrombin defect; Thyroid cancer, nonmedullary, 5; HABP2-related disorder | germline | 3 | Aug 09, 2021 | clinvar |